Scientific Presentations
PET amyloid imaging in clinical trials | Vendor Workshop at RSNA 2024
Jacob Dubroff, MD, PhD, associate professor of radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Amyloid PET in the diagnosis and management of patients with suspected Alzheimer disease | Vendor Workshop at RSNA 2024
Jana Ivanidze, MD, PhD, associate professor of radiology, Weill Cornell Medical College, New York, New York, USA
The exploration of ultra-low dose PET/CT and its implications for patient care | Vendor Workshop at RSNA 2024
Eliot Siegel, MD, medical director at United Theranostics, Minneapolis, Minnesota, USA
A powerful bond for cancer treatment: Incorporating molecular imaging with nuclear therapeutics
Prostate cancer radiopharmaceutical therapy: Beyond the basic | Vendor Workshop at RSNA 2023
Joseph R. Osborne, MD, PhD, Chief, Molecular Imaging and Therapeutics, Professor of Radiology, Director of the Radiology Health Equity Lab at New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New. York, USA.
PSMA PET: Technical and clinical case review | Vendor Workshop at RSNA 2023
Nicholas Feinberg, MD, Assistant Professor of Radiology, University of Chicago Medicine, Chicago, Illinois, USA.
EANM 2023 Lunch Symposium
Discover how Prof. Hacker envisions the potential of Total Body PET for whole person research and its effects on network medicine.
Symbia Pro.specta: Putting the "Pro" in SPECT/CT imaging
Empowering precision oncology: Expanding access to next-generation theranostics
Symbia Pro.specta SPECT/CT at SNMMI 2022
Learn more about the features and benefits of Symbia Pro.spectaâ„¢ SPECT/CT at SNMMI 2022.
Biograph Vision Quadra PET/CT at SNMMI 2022
Learn more about the features and benefits of Biograph Vision Quadraâ„¢ PET/CT at SNMMI 2022.
First clinical experiences with Symbia Pro.specta SPECT/CT
Laura Whitehouse
Dr. Erin Ross
Queen Elizabeth Hospital, Birmingham, UK
Radiomics and genomics – a match made in heaven?
Division of Nuclear Medicine
Medical University of Vienna
Quantification of myocardial 99mTc-HMDP uptake in patients with transthyretin-related cardiac amyloidosis: ready for clinical practice?
Nuclear Medicine Dept-Humani TEP; Faculty of Medicine
Integrated Intelligence in Molecular Imaging: Today and Tomorrow
Carl von Gall, MD
